Lisa Dooley is currently the Head of Quantitative Sciences for Interventional Oncology at Johnson & Johnson, where they support the development of patient solutions for lung cancer. Previously, they served as Senior Director and Therapeutic Area Leader for Immunology at The Janssen Pharmaceutical Companies, developing program strategies and leading cross-functional teams. Lisa has a robust educational background with a DrPH in Biostatistics and an MS in Biostatistics from the University of North Carolina at Chapel Hill, and they are currently pursuing a Bachelor of Arts in Mathematics and Statistics at Boston University. Their earlier career includes roles in biostatistics at both Johnson & Johnson and Merck.
This person is not in the org chart
This person is not in any teams
This person is not in any offices